| | | | | |
PFO Flaherty & Crumrine Preferred and Income Opportunity Fund Incorporated | $9,1800 | +0,33% | $118,87M | $16,30K | |
PLYX Polaryx Therapeutics, Inc. Common Stock | $2,2700 | +3,65% | $118,83M | $44,23K | |
PGAC Pantages Capital Acquisition Corporation Class A Ordinary Shares | $10,7350 | +0,52% | $118,41M | $17,00 | |
DMO Western Asset Mortgage Opportunity Fund Inc. | $10,4100 | +0,19% | $118,27M | $26,58K | |
ENGN enGene Therapeutics Inc. Common Stock | $1,7900 | +1,13% | $117,90M | $614,45K | |
ANIX Anixa Biosciences, Inc. | $3,4100 | +0,00% | $117,71M | $179,48K | |
OPRX OptimizeRx Corporation Common Stock | $6,8300 | +4,28% | $117,65M | $148,71K | |
| $1,0450 | +2,45% | $117,55M | $774,06K | |
JELD JELD-WEN Holding, Inc. | $1,8100 | +25,69% | $117,16M | $6,39M | |
MCN XAI Madison Equity Premium Income Fund | $5,6000 | -0,71% | $117,14M | $71,49K | |
WSBK Winchester Bancorp, Inc. Common Stock | $13,0100 | -0,23% | $117,11M | $2,77K | |
NEOV NeoVolta Inc. Common Stock | $2,5250 | +2,23% | $116,95M | $1,08M | |
BRKH Burtech Acquisition Corp II Class A Ordinary Shares | $9,9460 | +0,06% | $116,90M | $64,00 | |
| $8,5300 | +5,18% | $116,86M | $32,90K | |
MBOT Microbot Medical, Inc. Common Stock | $1,8400 | +3,96% | $116,86M | $605,98K | |
